DSD-C019

Congenital adrenal hyperplasia · 46,XX · DSD-C019

DSD-C019 · Congenital adrenal hyperplasia · 2025

Genes CYP11B1 · Karyotype 46,XX · Phenotypes HPO:0000047, Hypospadias (HP:0000047)

Not reported · Parameter Value Weight +3 SD Height +2 SD Pubic hair Tanner stage 3 Cortisol 5.6 µg/dL (normal 5–25 µg/dL) 17-OHP 8.6 ng/mL (normal <0.89 ng/mL) 11-deoxycorticosterone 6,056 pg/mL (normal 20–13 pg/mL) Bone age 10 years Karyotype 46,XX Genetic testing CYP11B1 mutation

Images · 2

Case fields and evidence

Category

Congenital adrenal hyperplasia

Sex

The legal guardian chose to maintain male sex because the child was raised as a boy.

Karyotype

46,XX

Genetics

CYP11B1

Phenotypes

Hypospadias (HP:0000047)

Diagnosis

Not reported · Parameter Value Weight +3 SD Height +2 SD Pubic hair Tanner stage 3 Cortisol 5.6 µg/dL (normal 5–25 µg/dL) 17-OHP 8.6 ng/mL (normal <0.89 ng/mL) 11-deoxycorticosterone 6,056 pg/mL (normal 20–13 pg/mL) Bone age 10 years Karyotype 46,XX Genetic testing CYP11B1 mutation

Follow-up

The patient was referred to a pediatrician for further investigation, but the parents did not follow up. Masculinizing surgery was proposed; however, the parents were lost to follow-up. Parameter Value Weight −1.5 SD Height −2 SD Pubic hair Tanner stage 5 Breast Tanner stage 4 External genitalia Prader stage 5 Follicle-stimulating hormone 4.48 mIU/mL (normal 2–13) Luteinizing hormone 2.04 mIU/mL (normal 1.5–8) Estradiol 52.23 pg/mL (34–186) Pelvic ultrasound Pubertal-sized uterus and left parauterine structure 11 mm high (left ovary)

General phenotype

The remainder of the physical examination showed hyperpigmentation of the hands, feet, and face. The parents were informed of available treatment options to align phenotypic sex with genotypic sex.

Imaging

Pelvic ultrasound was performed, showing a pubertal-sized uterus, 40 mm long, with a thin regular endometrium, and a left parauterine structure 11 mm high resembling the left ovary; the right ovary was not visualized (

Laboratory findings

Not reported

Management

The patient was started on hydrocortisone 20 mg/m². The parents were informed of available treatment options to align phenotypic sex with genotypic sex. Masculinizing surgery was proposed; however, the parents were lost to follow-up.

Pathology

Not reported

Evidence level

See source

Clinical history

See source

Perinatal history

See source

Family history

See source

Growth and development

See source

External genital examination

See source

Puberty / Tanner

See source

Cite this resource

DSD Research Library | Congenital adrenal hyperplasia · 46,XX · DSD-C019 | v1.4.0 | 2026-11-17 | https://dsdatlas.com/en/cases/DSD-C019?version=v1.4.0